Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06212596Phase 2Completed
Selinexor, Cyclophosphamide and Prednisone in Myeloma
Relapsed or Refractory Multiple Myeloma
PrincipalinvestigatorStart date: 2018-07-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Institute of Cancer Research, United Kingdom

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yang Xiao, MD

Shenzhen Nanshan District Shekou People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Gang An

Institute of Hematology & Blood Diseases Hospital Ethics Committee

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Marc S. Raab, PD Dr. med.

Medizinische Klinik V, University Hospital Heidelberg

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Jin Lu, PhD

Peking University People's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Sven Gogov, MD

Incyte Corporation

Moderately Similar
3 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Ravi Vij, M.D.

Washington Universtiy in St. Louis

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Jianmin luo, PhD&MD

The Second Hospital of Hebei Medical University

Moderately Similar
4 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Amitabha Mazumder, MD

NYU Langone Health

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Lugui Qiu

Chinese Academy of Medical Sciences & Peking Union Medical College

Moderately Similar
1 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Qing Zhang, Doctoral

Guangdong Second Provincial General Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Relapsed or Refractory Multiple Myeloma
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06212596Phase 2PrincipalInvestigator

Selinexor, Cyclophosphamide and Prednisone in Myeloma

Relapsed or Refractory Multiple Myeloma
Completed

All 1 trials loaded